Securing Affordable Treatments for All Americans

Left unchecked, the pharmaceutical industry continues to set exorbitant drug prices and hinder competition in the marketplace. ACHP advocates for policies that promote reasonable prescription drug prices and ensure a sustainable health care system that works for patients and health plans alike. ACHP is dedicated to cracking down on anticompetitive practices, spurring development of generic and biosimilar treatments and increasing transparency around price setting.

To the Point
Deep Dive


PROBLEM: Current law unintentionally prevents most seniors in high-quality MA plans from receiving expanded benefits, reduced premiums and/or lower co-pays. Counties across the country are hurt by a limit known as the MA benchmark cap. It is unfair to penalize seniors based on where they live.

SOLUTION: Congress can remedy this by paying full MA quality bonuses. The Medicare Advantage Quality Payment Relief Act (S. 1114H.R. 2131) ensures seniors enrolled in high quality MA plans receive full benefits and are not hurt by the cap. Learn more here.

Resource Library Search